Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Open Access
- 1 April 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 136 (7) , 2375-2381
- https://doi.org/10.4049/jimmunol.136.7.2375
Abstract
Although class II antigens encoded by genes in the major histocompatibility complex (MHC) are important as recognition structures for immunoregulatory cell interactions, the precise functional role of these molecules in the biological responses of B lymphocytes is unknown. In the studies described here, we have examined the effects of six monoclonal antibodies reactive with human class II MHC antigens on B cell activation and proliferation. Peripheral blood IgM+ B cells purified by fluorescence-activated cell sorter (FACS) techniques were stimulated with anti-mu antibodies, protein A-bearing Staphylococcus aureus (SAC), or in T cell-dependent activation cultures. The B cell proliferative responses induced by these stimuli were inhibited 68 to 90% by low concentrations (1 to 5 micrograms/ml) of antibodies reactive with class II MHC antigens. Antibodies specific for DR and DQ antigens were both effective inhibitors of B cell proliferation. This inhibition was not due to the binding of antibody to B cell Fc-IgG receptors, because IgM and IgG anti-class II antibodies were equally potent as inhibitors. When responses of B cells fractionated on the basis of cell size by forward angle light scatter were analyzed, anti-DR and anti-DQ antibodies inhibited the proliferation of small, resting IgM+ cells induced by T-independent as well as T-dependent stimuli. Activation-dependent increases in B cell size and RNA synthesis were similarly inhibited. In contrast, the responses of large B cells (that had been preactivated in vivo) to T cell-derived B cell growth factors were not affected by anti-class II antibodies. These data suggest that class II MHC molecules do not serve merely as cellular interaction structures but also directly participate in early events of the B cell activation cascade that precede cell enlargement or increased RNA synthesis. After activation and expression of receptors for growth factors, however, B cell class II MHC antigens no longer mediate signals required for mitogenesis.This publication has 32 references indexed in Scilit:
- In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.The Journal of Experimental Medicine, 1981
- In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.Proceedings of the National Academy of Sciences, 1981
- Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.The Journal of Immunology, 1981
- Major histocompatibility complex-restricted self recognition. A monoclonal anti-I-Ak reagent blocks helper T cell recognition of self major histocompatibility complex determinants.The Journal of Experimental Medicine, 1980
- Effects of blocking helper T cell induction in vivo with anti-Ia antibodies. Possible role of I-A/E hybrid molecules as restriction elements.The Journal of Experimental Medicine, 1980
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. II. Evidence for restrictions affecting helper cell induction and T-B collaboration, both mapping to the K-end of the H-2 complex.The Journal of Experimental Medicine, 1978
- CELLULAR AND GENETIC-CONTROL OF ANTIBODY-RESPONSES INVITRO .4. EXPRESSION OF IA ANTIGENS ON ACCESSORY CELLS REQUIRED FOR RESPONSES TO SOLUBLE-ANTIGENS INCLUDING A RESPONSE UNDER IR GENE CONTROL1978
- In vitro analysis of allogeneic lymphocyte interaction. I. Characterization and cellular origin of an Ia-positive helper factor- allogeneic effect factorThe Journal of Experimental Medicine, 1977
- Fc receptor-mediated inhibition of murine B-lymphocyte activation.The Journal of Experimental Medicine, 1976